These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 32690258)
1. Discovery of [1,2,4]triazolo[4,3-a]pyridines as potent Smoothened inhibitors targeting the Hedgehog pathway with improved antitumor activity in vivo. Tian N; Wu H; Zhang H; Yang D; Lv L; Yang Z; Zhang T; Quan D; Zhou L; Xie Y; Xu Y; Wei N; Zhang J; Chen M; Schmitz JC; Tian Y; Wu S Bioorg Med Chem; 2020 Aug; 28(16):115584. PubMed ID: 32690258 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616 [TBL] [Abstract][Full Text] [Related]
3. Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers. Li QR; Zhao H; Zhang XS; Lang H; Yu K Acta Pharmacol Sin; 2019 Feb; 40(2):257-267. PubMed ID: 29777201 [TBL] [Abstract][Full Text] [Related]
4. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro. You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913 [TBL] [Abstract][Full Text] [Related]
5. Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity. Zhang H; Sun Z; Liu Z; Song C Future Med Chem; 2018 Dec; 10(24):2855-2875. PubMed ID: 30557039 [TBL] [Abstract][Full Text] [Related]
6. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance. Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and Bioavailability Study of a Novel Smoothened Inhibitor TPB15 for Treatment of Triple-Negative Breast Cancer in Rats by High Performance Liquid Chromatography-Mass Spectrometry. Chen BY; Xu JH; Chen QQ; Wu HX; Ou BF; Zhou Z; Xu F; Wu SY; Xie SL; Wen DS Eur J Drug Metab Pharmacokinet; 2024 Sep; 49(5):645-655. PubMed ID: 39158678 [TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis. Doheny D; Sirkisoon S; Carpenter RL; Aguayo NR; Regua AT; Anguelov M; Manore SG; Arrigo A; Jalboush SA; Wong GL; Yu Y; Wagner CJ; Chan M; Ruiz J; Thomas A; Strowd R; Lin J; Lo HW Oncogene; 2020 Oct; 39(42):6589-6605. PubMed ID: 32929154 [TBL] [Abstract][Full Text] [Related]
9. A New Smoothened Antagonist Bearing the Purine Scaffold Shows Antitumour Activity In Vitro and In Vivo. Zárate AM; Espinosa-Bustos C; Guerrero S; Fierro A; Oyarzún-Ampuero F; Quest AFG; Di Marcotullio L; Loricchio E; Caimano M; Calcaterra A; González-Quiroz M; Aguirre A; Meléndez J; Salas CO Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445078 [TBL] [Abstract][Full Text] [Related]
10. Posaconazole, a Second-Generation Triazole Antifungal Drug, Inhibits the Hedgehog Signaling Pathway and Progression of Basal Cell Carcinoma. Chen B; Trang V; Lee A; Williams NS; Wilson AN; Epstein EH; Tang JY; Kim J Mol Cancer Ther; 2016 May; 15(5):866-76. PubMed ID: 26823493 [TBL] [Abstract][Full Text] [Related]
11. A novel hedgehog inhibitor for the treatment of hematological malignancies. Lin P; He Y; Chen G; Ma H; Zheng J; Zhang Z; Cao B; Zhang H; Zhang X; Mao X Anticancer Drugs; 2018 Nov; 29(10):995-1003. PubMed ID: 30106753 [TBL] [Abstract][Full Text] [Related]
12. A sterol analog inhibits hedgehog pathway by blocking cholesterylation of smoothened. Liu YB; He LM; Sun M; Luo WJ; Lin ZC; Qiu ZP; Zhang YL; Hu A; Luo J; Qiu WW; Song BL Cell Chem Biol; 2024 Jul; 31(7):1264-1276.e7. PubMed ID: 38442710 [TBL] [Abstract][Full Text] [Related]
13. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells. Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905 [TBL] [Abstract][Full Text] [Related]
14. ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic. Wang J; Zhang Y; Huang WJ; Yang J; Tang WG; Huang TM; Tan WF Acta Pharmacol Sin; 2021 Jun; 42(6):1005-1013. PubMed ID: 32855528 [TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related]
16. Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis. Chen Q; Zhang H; Wu M; Wang Q; Luo L; Ma H; Zhang X; He S J Pharmacol Sci; 2018 Jul; 137(3):256-264. PubMed ID: 30064819 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Ramaswamy B; Lu Y; Teng KY; Nuovo G; Li X; Shapiro CL; Majumder S Cancer Res; 2012 Oct; 72(19):5048-59. PubMed ID: 22875023 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Hedgehog Signaling in Fibroblasts, Pancreatic, and Lung Tumor Cells by Oxy186, an Oxysterol Analogue with Drug-Like Properties. Wang F; Stappenbeck F; Parhami F Cells; 2019 May; 8(5):. PubMed ID: 31137846 [TBL] [Abstract][Full Text] [Related]
19. Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity. Sinha N; Chowdhury S; Sarkar RR Proteins; 2020 Mar; 88(3):514-526. PubMed ID: 31589795 [TBL] [Abstract][Full Text] [Related]
20. Design and biological evaluation of phenyl imidazole analogs as hedgehog signaling pathway inhibitors. Sun C; Zhang Y; Wang H; Yin Z; Wu L; Huang Y; Zhang W; Wang Y; Hu Q Chem Biol Drug Des; 2021 Mar; 97(3):546-552. PubMed ID: 32946174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]